Skip to content
OpenCapital
Get started

BioSig Technologies, Inc. STEX Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value

Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value at other companies

Tradeweb Markets Inc. logo
Tradeweb Markets Inc.TW
——

Other financials

Income statement

See full
Revenue$13.0K+8.3%
Gross profit$12.0K-88.9%
Operating income-$35.7M-1,098%
Net income-$46.7M-1,560%
EPS (diluted)-$0.27-92.9%

Balance sheet

See full
Cash & equivalents$6.9M+84.0%
Total debt$15.0K-94.7%
Total equity$159.0M+6,003%
Total assets$173.3M+3,823%

Cash flow

See full
Operating cash flow-$10.2M-813%
CapEx$4.0K-93.1%
Free cash flow-$2.9M+29.4%

Valuation

See full
Market cap$88.66M-56.4%
P/S2,216.6×-5,967×

Profitability

See full
Gross margin80.1%+25.2pp
Operating margin-32,155%-14,261pp
Net margin-25,825%-11,789pp
FCF margin-97,216.7%-106,293pp

Returns & leverage

See full
Return on equity-627.1%—
Debt / equity0×—
Current ratio13.9×+11.5×

Where this comes from

Reported directly by BioSig Technologies, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue.

The official record: BioSig Technologies, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioSig Technologies, Inc.'s share-based compensation arrangement by share-based payment award, options, outstanding, intrinsic value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BioSig Technologies, Inc.'s share-based compensation arrangement by share-based payment award, options, outstanding, intrinsic value?
BioSig Technologies, Inc. (STEX) reported share-based compensation arrangement by share-based payment award, options, outstanding, intrinsic value of $1.71B in Q1 2026.
How has BioSig Technologies, Inc.'s share-based compensation arrangement by share-based payment award, options, outstanding, intrinsic value changed year-over-year?
BioSig Technologies, Inc.'s share-based compensation arrangement by share-based payment award, options, outstanding, intrinsic value increased by 365.3% year-over-year, from $367.44M to $1.71B.
What is the long-term trend for BioSig Technologies, Inc.'s share-based compensation arrangement by share-based payment award, options, outstanding, intrinsic value?
Over 3 years (2022 to 2025), BioSig Technologies, Inc.'s share-based compensation arrangement by share-based payment award, options, outstanding, intrinsic value has grown at a 1210.0% compound annual growth rate (CAGR), from $3M to $6.74B.